Nuclear Structure of KMT2A-Rearranged Infant ALL

被引：0
|
作者：
Namikawa, Yui [1 ]
Muhaimin, Riski [1 ]
Tomomasa, Dan [1 ]
Nishimura, Akira [1 ]
Ishii, Eiichi [2 ]
Tomizawa, Daisuke [3 ]
Miyamura, Takako [4 ]
Isoda, Takeshi [1 ]
Takagi, Masatoshi [1 ]
机构：
[1] Tokyo Med & Dent Univ, Pediat & Dev Biol, Tokyo, Japan
[2] Imabari City Med Assoc Shimin Hosp, Imabari, Japan
[3] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[4] Osaka Univ, Grad Sch Med, Osaka, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1293
引用
收藏
页码：563 / 563
页数：1
相关论文
共 50 条
  • [1] Allelic imbalance in KMT2A-rearranged infant acute lymphoblastic leukemia
    Yoo, Byunggil
    Farooqi, Midhat S.
    Kostadinov, Rumen
    Cheung, Warren
    Farrow, Emily
    Kelley, Shannon
    Miller, Neil
    Ge, Bing
    Gibson, Margaret
    Brown, Patrick
    Guest, Erin M.
    Pastinen, Tomi
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Cheung, Laurence C.
    de Kraa, Rebecca
    Oommen, Joyce
    Chua, Grace-Alyssa
    Singh, Sajla
    Hughes, Anastasia M.
    Ferrari, Emanuela
    Ford, Jette
    Chiu, Sung K.
    Stam, Ronald W.
    Kees, Ursula R.
    Malinge, Sebastien
    Kotecha, Rishi S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia
    Chiu, Sung K.
    Ferrari, Emanuela
    Oommen, Joyce
    Malinge, Sebastien
    Cheung, Laurence C.
    Kotecha, Rishi S.
    CANCERS, 2025, 17 (03)
  • [4] AZACITIDINE AS EPIGENETIC PRIMING FOR CHEMOTHERAPY IS SAFE IN INFANTS WITH KMT2A-REARRANGED ALL
    Guest, Erin
    Kairalla, John
    Devidas, Meenakshi
    Hibbitts, Emily
    Carroll, Andrew
    Heerema, Nyla
    Kubaney, Holly
    August, Amanda
    Pauly, Melinda
    Wechsler, Daniel
    Miles, Rodney
    Reid, Joel
    Kihei, Cynthia
    Gore, Lia
    Raetz, Elizabeth
    Hunger, Stephen
    Loh, Mignon
    Brown, Patrick
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S5 - S6
  • [5] ACUTE ENCEPHALOPATHY FOLLOWING TUMOR LYSIS SYNDROME IN AN INFANT WITH KMT2A-REARRANGED LEUKEMIA
    Murasawa, Reina
    Ashiarai, Miho
    Yoshihara, Hiroki
    Umehara, Naoki
    Nakatani, Ryo
    Ono, Rintaro
    Hosoya, Yosuke
    Yokoyama, Mina
    Nozaki, Taiki
    Hasegawa, Daisuke
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [6] KMT2A-Rearranged DLBCL Refractory to Intensive Chemotherapy
    Kubota, Y.
    Sekiguchi, M.
    Watanabe, K.
    Oka, A.
    Miyano, S.
    Ogawa, S.
    Takita, J.
    Hiwatari, M.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S185 - S186
  • [7] PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch
    Nakajima, Koji
    Kubota, Hirohito
    Kato, Itaru
    Isobe, Kiyotaka
    Ueno, Hiroo
    Kozuki, Kagehiro
    Tanaka, Kuniaki
    Kawabata, Naoko
    Mikami, Takashi
    Tamefusa, Kosuke
    Nishiuchi, Ritsuo
    Saida, Satoshi
    Umeda, Katsutsugu
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Takita, Junko
    CANCER SCIENCE, 2022, 113 (07) : 2472 - 2476
  • [8] Fusion transcripts are present in early progenitor cells in KMT2A-rearranged B-ALL
    Tirtakusuma, Ricky
    Milne, Paul
    Blair, Helen J.
    Shi, Yuzhe
    Bomken, Simon
    Heidenreich, Olaf
    LEUKEMIA, 2024, 38 (04) : 883 - 886
  • [9] Fusion transcripts are present in early progenitor cells in KMT2A-rearranged B-ALL
    Ricky Tirtakusuma
    Paul Milne
    Helen J. Blair
    Yuzhe Shi
    Simon Bomken
    Olaf Heidenreich
    Leukemia, 2024, 38 : 883 - 886
  • [10] Epigenetic regulation of protein translation in KMT2A-rearranged AML
    Lenard, Alexandra
    Xie, Hongbo Michael
    Pastuer, Taylor
    Shank, Tyler
    Libbrecht, Clara
    Kingsley, Molly
    Riedel, Simone S.
    Yuan, Zuo-Fei
    Zhu, Nan
    Neff, Tobias
    Bernt, Kathrin M.
    EXPERIMENTAL HEMATOLOGY, 2020, 85 : 57 - 69
12345